ProCE Banner Activity

A Thorough Analysis of Global Racial Disparities in HBV Care

Text Module

Thorough analysis of barriers to screening, evaluation, and treatment of HBV in migrant populations and racial/ethnic minorities.

Released: December 10, 2021

Expiration: December 09, 2022

No longer available for credit.

Share

Faculty

Mindie H. Nguyen

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine
Department of Gastroenterology and Hepatology
Stanford University Medical Center
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Partners

AHF

ProCE Banner

BAI

ProCE Banner

Hep C Trust

ProCE Banner

IAS 2021

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare providers who provide care for patients with or at risk of HIV.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply plans to improve engagement across the care continuum for HBV by combatting race-related barriers
  • Implement strategies to combat implicit racial biases that affect optimal care of individuals with or at risk of HBV

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosure

Primary Author

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine
Department of Gastroenterology and Hepatology
Stanford University Medical Center
Palo Alto, California

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD, has disclosed that she has received funds for research support from Gilead Sciences and Vir and consulting fees from Exact Sciences, Gilead Sciences, Janssen, Lilly, Novartis, and Spring Bank.

Staff Disclosure

Staff

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Jill A. Sakai,

Contributing Editor

Jill Sakai, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, has no relevant conflicts of interest to report.

Courtney Smith, PharmD, MS

Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Program Medium

This program has been made available online.

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

 

Goal


The goal of this activity is to improve clinicians’ competence in recognizing and combatting racial disparities in care for persons with or at risk of HIV infection in the United States.